Latest news

CSO, Tyler Korman

Co-founder of eXoZymes and cell-free biomanufacturing pioneer, Tyler Korman, speaks to his new role as CSO

CEO, Michael Heltzen is interviewed by Jane King

Jane King interviews CEO, Michael Heltzen, in New York

Tyler Korman: How is eXoZymes uniquely positioned to take advantage of AI?

Tyler Korman: How is eXoZymes uniquely positioned to take advantage of AI?

2025 Q3 Earnings Call

eXoZymes to host third quarter 2025 update on Thursday November 13, 2025, at 5PM EST

CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference

CEO of eXoZymes on ‘AI in Life Sciences’ panel at the Beryl Elites’ Investment Conference

Spartan Capital Annual Investor Conference

CEO of eXoZymes to Present at Spartan Capital Securities’ Second Annual Investor Conference

CEO of eXoZymes to Present at ThinkEquity’s Annual Investor Conference

Podcast: 'The Catalyst' interviews CEO, Michael Heltzen

Zachary Karl, Vice President Business Development @ Bio Innovations Midwest 2025

World Bio Markets: AI - A tool U.S. industrial biomanufacturing cannot ignore

Inside Biotech podcast interviews CEO, Michael Heltzen

Podcast: 'Inside Biotech' interviews CEO, Michael Heltzen